|Bid||59.86 x 800|
|Ask||66.00 x 800|
|Day's Range||59.94 - 61.15|
|52 Week Range||44.29 - 67.06|
|Beta (3Y Monthly)||0.89|
|PE Ratio (TTM)||37.21|
|Earnings Date||Apr 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||65.36|
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. One great example is ExlService Holdings, Inc. (NASDAQ:EXLS...
Exlservice Holdings Inc NASDAQ/NGS:EXLSView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for EXLS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting EXLS. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold EXLS had net inflows of $2.48 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Industrials sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
NEW YORK, April 04, 2019 -- ExlService Holdings, Inc. (“EXL”) (NASDAQ: EXLS), a leading operations management and analytics company, will announce financial results for its.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Small-caps and large-caps are wildly popular among investors, however, mid-cap stocks, such as ExlService Holdings, Inc. (NAS...
Measuring ExlService Holdings, Inc.'s (NASDAQ:EXLS) track record of past performance is an insightful exercise for investors. It enables us to reflect on whether the company has met or exceed expectations,Read More...
2018 Fourth Quarter Revenues of $234.9 Million, up 18.7% year-over-yearQ4 Diluted EPS (GAAP) of $0.11(1), up from ($0.27)(2) in Q4 of 2017Q4 Adjusted Diluted EPS (Non-GAAP) of.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! One of the best investments we can make is inRead More...
ExlService Holdings (EXLS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ExlService Holdings, Inc. (NASDAQ:EXLS) is a small-cap stock with a market capitalization of US$2.0b. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they Read More...
NEW YORK, Jan. 24, 2019 -- ExlService Holdings, Inc. (“EXL”) (NASDAQ: EXLS), a leading operations management and analytics company, will announce financial results for its.
Rohit Kapoor became the CEO of ExlService Holdings, Inc. (NASDAQ:EXLS) in 2008. This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we'll Read More...
EXL (EXLS), a leading operations management and analytics company, today announced that it is pursuing a go-to-market strategy with PharmaCord, LLC, a rapidly growing patient services company that provides customized solutions to the life sciences industry, to develop advanced analytics solutions that accelerate the effectiveness of patient support programs on behalf of biopharmaceutical manufacturers. “Patients continue to experience significant challenges in accessing therapies critical to their treatment plan and quality of life,” said Rohit Kapoor, Vice Chairman and Chief Executive Officer, EXL. EXL expects to support PharmaCord in its efforts to develop further innovation to its proprietary, AI-powered CORscend platform, as well as provide other solutions that allow PharmaCord to create additional differentiation in its patient support programs for pharmaceutical clients.
NEW YORK, Nov. 07, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
ExlService Holdings (EXLS) delivered earnings and revenue surprises of 0.00% and -0.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the New York-based company said it had net income of 43 cents. Earnings, adjusted for amortization costs and stock option expense, were 71 cents per share. The results met Wall Street ...
2018 Third Quarter Revenues of $231.1 Million, up 20.2% year over year Q3 Diluted EPS (GAAP) of $0.43, down from $0.60 in Q3 of 2017 Q3 Adjusted Diluted EPS (Non-GAAP) of $0.71,.